Sign in
4

Changes in Ownership

RECURSION PHARMACEUTICALS, INC. Filed Acc 0001628280-24-038438

Chief Executive Officer acquired 5,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Gibson Christopher · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-08-26 Exercise or conversion : show line 1 in the form +5,000 $2.48 $12,400 742,656 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-08-26 Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) −5,000 302,500 D
Loading xslF345X05/wk-form4_1724704942.xml…